Document is current

Article History

Received: 29 April 2019

Accepted: 25 June 2019

First Online: 5 July 2019

Ethics approval and consent to participate

: The present study will be conducted according to the declarations of Helsinki on ethical principles for medical research involving human subjects (). In this line, ethical clearance has been obtained from the Cameroon National Ethics Committee for Research on Human Health in Cameroon (): reference number N^o2018/01/981/CE/CNERSH/SP. After an informed notice on the study, a written informed will be obtained from legal guardian, and a written assent will also be obtained from the participating ADLHIV, without any coercion. Privacy and confidentiality will be ensured, through the use of unique identifiers and a protected database, to protect personal information for participants. Participants will be free to deliberately leave the study at any time, without any effect on their routine monitoring at the study clinic. Phlebotomy will be non-invasive (venipuncture) and will be performed by qualified staffs. All laboratory results generated in the course of the study, including GRT, will be used for the selection of most effective ARV drugs available in the national guidelines of Cameroon (first-, second- and third-line regimens). Our research findings will be communicated for improved management and monitoring of the target population. Study information sheets and informed consents are provided as SDG-2.

: Not applicable.

: The authors declare that they have no competing interests.